Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
30 Year Tips/Tsy Spread Proshares | RINF | Jan 17, 2025 | 33.17 | +0.20 |
36Kr ADR | KRKR | Jan 17, 2025 | 3.39 | +3.02 |
374Water | SCWO | Jan 17, 2025 | 0.59 | -3.67 |
3D Systems | DDD | Jan 17, 2025 | 3.08 | -0.96 |
3M | MMM | Jan 17, 2025 | 141.03 | +1.33 |
4D Molecular Therapeutics | FDMT | Jan 17, 2025 | 4.58 | -2.14 |
51Talk Online Education Group ADR | COE | Jan 17, 2025 | 20.10 | +0.50 |
5E Advanced Materials | FEAM | Jan 17, 2025 | 0.47 | -4.25 |
60 Degrees Pharmaceuticals | SXTP | Jan 17, 2025 | 0.83 | +0.32 |
7-10 Yr Trsy Bear 3X Direxion | TYO | Jan 17, 2025 | 15.00 | -0.07 |
7-10 Yr Trsy Bull 3X Direxion | TYD | Jan 17, 2025 | 23.32 | 0.00 |
7-10 Yr Trsy Ishares | IEF | Jan 17, 2025 | 92.45 | +0.08 |
89bio | ETNB | Jan 17, 2025 | 6.31 | +3.53 |
8x8 | EGHT | Jan 17, 2025 | 2.58 | -2.27 |
908 Devices | MASS | Jan 17, 2025 | 2.98 | +2.76 |
9F ADR | JFU | Jan 17, 2025 | 1.52 | +4.83 |
A SPAC II Acquisition | ASCB | Jan 17, 2025 | 11.19 | 0.00 |
A-Mark Precious Metals | AMRK | Jan 17, 2025 | 27.28 | -1.34 |
a.k.a Brands | AKA | Jan 17, 2025 | 18.19 | +7.00 |
A.O Smith | AOS | Jan 17, 2025 | 71.81 | +0.57 |
A10 Networks | ATEN | Jan 17, 2025 | 18.96 | +1.28 |
A2Z Cust2Mate Solutions | AZ | Jan 17, 2025 | 7.00 | +0.29 |
AA Mission Acquisition | AAM | Jan 17, 2025 | 10.12 | 0.00 |
AAA - A Rated Corporate Bond Ishares | QLTA | Jan 17, 2025 | 46.78 | +0.11 |
Aadi Bioscience | AADI | Jan 17, 2025 | 2.98 | -4.79 |
AAON | AAON | Jan 17, 2025 | 130.18 | -1.03 |
AAR | AIR | Jan 17, 2025 | 70.21 | -0.57 |
Abacus Life | ABL | Jan 17, 2025 | 7.45 | +0.95 |
Abbott Laboratories | ABT | Jan 17, 2025 | 113.48 | -0.38 |
AbbVie | ABBV | Jan 17, 2025 | 171.56 | -1.23 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.